Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 3 New Influenza Virus Reassortants in Adults
NCT02473510Phase 4Completed
- Sponsor
- MedImmune
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by MedImmune. Started Jun 2015; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02473510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473510.